Home » Topics » BioWorld Science, Neurology/psychiatric

BioWorld Science, Neurology/psychiatric
RSS

NDA resubmission for indiplon capsules planned for Q2 2007

Jan. 24, 2007

Progress in phase II trial of AL-208 for MCI in CABG

Jan. 24, 2007

MBP-8298 cleared to begin U.S. phase III study in secondary progressive MS

Jan. 23, 2007

Nalbuphine ER begins phase I safety study for pain

Jan. 23, 2007

Tentative approval for Barr's generic version of Kytril

Jan. 23, 2007

Intravenous cannabinor shows no efficacy benefit in capsaicin-induced pain

Jan. 23, 2007

Inovelon approved in E.U. for Lennox-Gastaut syndrome

Jan. 22, 2007

Recent patents report novel analgesic agents

Jan. 22, 2007

Cipralex approved in Europe for OC

Jan. 22, 2007

Data on nitroflurbiprofen sets stage for clinical trials in DMD

Jan. 22, 2007

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...